SOMAscan-based proteomic measurements of plasma brain natriuretic peptide are decreased in mild cognitive impairment and in Alzheimer's dementia patients - Begic, Edin; Hadzidedic, Suncica; Kulaglic, Ajla; Ramic-Brkic, Belma; Begic, Zijo; Causevic, Mirsada (PloS one, 2019)
Keywords: Age; Aged; Aged, 80 and over; Aging; Alzheimer Disease - blood; Alzheimer's disease; Amino acids; Analysis; Apolipoprotein E4; Bioindicators; Biological markers; Biology and Life Sciences; Biomarkers; Biomarkers - blood; Brain; Brain natriuretic peptide; Brain research; Cardiology; Cardiovascular diseases; Cognitive ability; Cognitive disorders; Cognitive Dysfunction - blood; Computer and Information Sciences; Computer science; Congestive heart failure; Dementia; Dementia disorders; Diabetes; Engineering and Technology; Female; Gene expression; Genotypes; Health risks; Heart; Heart failure; Humans; Impairment; Information systems; Male; Measurement; Medical diagnosis; Medical research; Medicine and Health Sciences; Natriuretic Peptide, Brain - blood; Natriuretic peptides; Neurodegeneration; Neurodegenerative diseases; Older people; Patients; Peptides; Plasma levels; Proteomics; United Kingdom; Bosnia-Hercegovina